Gemini Therapeutics Sub

Gemini Therapeutics Sub is a precision medicine company focused on genetically-defined dry age-related macular degeneration and associated rare genetic diseases. Its therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and its broad multimodal pipeline includes monoclonal antibodies, recombinant proteins, and gene therapies.